We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Results: 3

1.

Figure. From: Selegiline shortage.

Figure 2 Monthly prescriptions filled for monoamine oxidase type B inhibitors approved for treatment of Parkinson disease (shortage first reported in September 2007)

E R. Dorsey, et al. Neurology. 2009 July 21;73(3):213-217.
2.

Figure. From: Selegiline shortage.

Figure 1 Monthly generic selegiline prescriptions filled, total and by large manufacturers, February 2002–December 2007
Source: IMS Health, IMS National Prescription Audit™, 02/2002–12/2007.

E R. Dorsey, et al. Neurology. 2009 July 21;73(3):213-217.
3.

Figure. From: Selegiline shortage.

Figure 3 Total monthly prescriptions filled for generic selegiline [primary (A) and other manufacturers (B)] and branded capsules (C), September 2006–December 2007
Scale of vertical axis differs between graphs. Source: IMS Health, IMS National Prescription Audit™, 02/2002–12/2008.

E R. Dorsey, et al. Neurology. 2009 July 21;73(3):213-217.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk